CSPC Financial Statements From 2010 to 2024
| CVGU Stock | EUR 2.26 0.04 1.74% |
Check CSPC PHARMACEUTGR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSPC PHARMACEUTGR's main balance sheet or income statement drivers, such as , as well as many indicators such as . CSPC financial statements analysis is a perfect complement when working with CSPC PHARMACEUTGR Valuation or Volatility modules.
CSPC |
CSPC PHARMACEUTGR ADR4 Company Price To Earning Analysis
CSPC PHARMACEUTGR's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current CSPC PHARMACEUTGR Price To Earning | 18.49 X |
Most of CSPC PHARMACEUTGR's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC PHARMACEUTGR ADR4 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, CSPC PHARMACEUTGR ADR4 has a Price To Earning of 18.49 times. This is 28.44% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The price to earning for all Germany stocks is 35.62% higher than that of the company.
CSPC PHARMACEUTGR ADR4 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSPC PHARMACEUTGR's current stock value. Our valuation model uses many indicators to compare CSPC PHARMACEUTGR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSPC PHARMACEUTGR competition to find correlations between indicators driving CSPC PHARMACEUTGR's intrinsic value. More Info.CSPC PHARMACEUTGR ADR4 is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers reporting about 1.19 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSPC PHARMACEUTGR's earnings, one of the primary drivers of an investment's value.About CSPC PHARMACEUTGR Financial Statements
CSPC PHARMACEUTGR stakeholders use historical fundamental indicators, such as CSPC PHARMACEUTGR's revenue or net income, to determine how well the company is positioned to perform in the future. Although CSPC PHARMACEUTGR investors may analyze each financial statement separately, they are all interrelated. For example, changes in CSPC PHARMACEUTGR's assets and liabilities are reflected in the revenues and expenses on CSPC PHARMACEUTGR's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CSPC PHARMACEUTGR ADR4. Please read more on our technical analysis and fundamental analysis pages.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. CSPC PHARMACEUT operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21527 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Stock
CSPC PHARMACEUTGR financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC PHARMACEUTGR security.